{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:14:09Z","timestamp":1770725649415,"version":"3.49.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0225178","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T19:13:14Z","timestamp":1573845194000},"page":"e0225178","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Detection of early-stage Alzheimer\u2019s pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients"],"prefix":"10.1371","volume":"14","author":[{"given":"Cassandra","family":"DeMarshall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahil","family":"Kheirkhah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick","family":"Sieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Nagele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"issue":"4","key":"pone.0225178.ref001","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.pneurobio.2011.07.004","article-title":"Neurodegenerative disease biomarkers: guideposts for disease prevention through early diagnosis and intervention","volume":"95","author":"JQ Trojanowski","year":"2011","journal-title":"Prog Neurobiol"},{"issue":"3","key":"pone.0225178.ref002","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","article-title":"2019 Alzheimer's disease facts and figures","volume":"15","year":"2019","journal-title":"Alzheimer's & Dementia"},{"issue":"9533","key":"pone.0225178.ref003","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"K Blennow","year":"2006","journal-title":"Lancet"},{"issue":"4","key":"pone.0225178.ref004","first-page":"208","article-title":"Drugs for Alzheimer's disease: are they effective?","volume":"35","author":"DA Casey","year":"2010","journal-title":"P T"},{"issue":"9","key":"pone.0225178.ref005","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"RJ Bateman","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0225178.ref006","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories","volume":"18","author":"H Braak","year":"1997","journal-title":"Neurobiol Aging"},{"issue":"19","key":"pone.0225178.ref007","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.191044198","article-title":"Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose\/poitron-emission tomography (FDG\/PET).","volume":"98","author":"MJ de Leon","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"pone.0225178.ref008","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/00005072-199812000-00009","article-title":"Neuropathological and neuropsychological changes in \"normal\" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals","volume":"57","author":"CM Hulette","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"pone.0225178.ref009","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1212\/WNL.46.3.707","article-title":"Cerebral amyloid deposition and diffuse plaques in \"normal\" aging: Evidence for presymptomatic and very mild Alzheimer's disease","volume":"46","author":"JC Morris","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"pone.0225178.ref010","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and \"preclinical\" Alzheimer's disease","volume":"45","author":"JL Price","year":"1999","journal-title":"Ann Neurol"},{"issue":"4","key":"pone.0225178.ref011","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2174\/156720509788929237","article-title":"Early diagnosis of Alzheimer's disease: is MCI too late?","volume":"6","author":"RC Petersen","year":"2009","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"pone.0225178.ref012","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jalz.2014.02.004","article-title":"Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease.","volume":"11","author":"K Blennow","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"12","key":"pone.0225178.ref013","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/01.wnl.0000345014.48839.71","article-title":"CSF biomarkers in relationship to cognitive profiles in Alzheimer disease","volume":"72","author":"AE van der Vlies","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"pone.0225178.ref014","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"RC Petersen","year":"1999","journal-title":"Arch Neurol"},{"issue":"3","key":"pone.0225178.ref015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"MS Albert","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"1","key":"pone.0225178.ref016","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jalz.2013.01.013","article-title":"The future of blood-based biomarkers for Alzheimer's disease","volume":"10","author":"K Henriksen","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"3","key":"pone.0225178.ref017","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.jalz.2010.06.004","article-title":"Biomarkers in Alzheimer's disease drug development","volume":"7","author":"JL Cummings","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"3","key":"pone.0225178.ref018","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"K Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"pone.0225178.ref019","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/acn3.274","article-title":"CSF Abeta42\/Abeta40 and Abeta42\/Abeta38 ratios: better diagnostic markers of Alzheimer disease","volume":"3","author":"S Janelidze","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"pone.0225178.ref020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1749-6632.2009.04944.x","article-title":"CSF biomarkers: pinpointing Alzheimer pathogenesis","volume":"1180","author":"N Mattsson","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"pone.0225178.ref021","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1373\/clinchem.2013.202937","article-title":"Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-beta(1\u201342) and tau proteins as Alzheimer disease biomarkers","volume":"59","author":"JH Kang","year":"2013","journal-title":"Clin Chem"},{"key":"pone.0225178.ref022","first-page":"135","article-title":"Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease","volume":"2","author":"GP Morris","year":"2014","journal-title":"Acta Neuropathol Commun"},{"issue":"11","key":"pone.0225178.ref023","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer's disease concord with amyloid-beta PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.","volume":"14","author":"O Hansson","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"9","key":"pone.0225178.ref024","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archneurol.2011.105","article-title":"Comparison of analytical platforms for cerebrospinal fluid measures of beta-amyloid 1\u201342, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology","volume":"68","author":"AM Fagan","year":"2011","journal-title":"Arch Neurol"},{"issue":"3","key":"pone.0225178.ref025","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"T Tapiola","year":"2009","journal-title":"Arch Neurol"},{"issue":"1","key":"pone.0225178.ref026","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jalz.2016.09.014","article-title":"Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic","volume":"13","author":"SE O'Bryant","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"12","key":"pone.0225178.ref027","doi-asserted-by":"crossref","first-page":"e28092","DOI":"10.1371\/journal.pone.0028092","article-title":"A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI","volume":"6","author":"SE O'Bryant","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"pone.0225178.ref028","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jalz.2014.08.099","article-title":"Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research","volume":"11","author":"SE O'Bryant","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"6","key":"pone.0225178.ref029","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jalz.2013.09.016","article-title":"Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology.","volume":"10","author":"M Sattlecker","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"4","key":"pone.0225178.ref030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"M Mapstone","year":"2014","journal-title":"Nat Med"},{"issue":"1","key":"pone.0225178.ref031","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13195-018-0448-x","article-title":"A two-step immunoassay for the simultaneous assessment of Abeta38, Abeta40 and Abeta42 in human blood plasma supports the Abeta42\/Abeta40 ratio as a promising biomarker candidate of Alzheimer's disease","volume":"10","author":"H Shahpasand-Kroner","year":"2018","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"pone.0225178.ref032","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jamaneurol.2018.4666","article-title":"Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes","volume":"76","author":"MP Pase","year":"2019","journal-title":"JAMA Neurol"},{"issue":"3","key":"pone.0225178.ref033","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3233\/JAD-130380","article-title":"Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study","volume":"38","author":"SJ Kiddle","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"pone.0225178.ref034","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fgene.2013.00150","article-title":"The detection of microRNA associated with Alzheimer's disease in biological fluids using next-generation sequencing technologies","volume":"4","author":"L Cheng","year":"2013","journal-title":"Front Genet"},{"issue":"4","key":"pone.0225178.ref035","doi-asserted-by":"crossref","first-page":"e60726","DOI":"10.1371\/journal.pone.0060726","article-title":"Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease","volume":"8","author":"EP Nagele","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"pone.0225178.ref036","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.imlet.2015.09.010","article-title":"Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease","volume":"168","author":"CA DeMarshall","year":"2015","journal-title":"Immunol Lett"},{"key":"pone.0225178.ref037","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.dadm.2016.03.002","article-title":"Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers","volume":"3","author":"CA DeMarshall","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"issue":"2","key":"pone.0225178.ref038","doi-asserted-by":"crossref","first-page":"e32383","DOI":"10.1371\/journal.pone.0032383","article-title":"Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera","volume":"7","author":"M Han","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"pone.0225178.ref039","doi-asserted-by":"crossref","first-page":"e23112","DOI":"10.1371\/journal.pone.0023112","article-title":"Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera","volume":"6","author":"E Nagele","year":"2011","journal-title":"PLoS One"},{"key":"pone.0225178.ref040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2017.05.010","article-title":"Autoantibodies as diagnostic biomarkers for the detection and subtyping of multiple sclerosis","volume":"309","author":"C DeMarshall","year":"2017","journal-title":"J Neuroimmunol"},{"issue":"11","key":"pone.0225178.ref041","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/jamasurg.2018.2602","article-title":"Effect of Depth of Sedation in Older Patients Undergoing Hip Fracture Repair on Postoperative Delirium: The STRIDE Randomized Clinical Trial","volume":"153","author":"FE Sieber","year":"2018","journal-title":"JAMA Surg"},{"issue":"9","key":"pone.0225178.ref042","doi-asserted-by":"crossref","first-page":"e0204695","DOI":"10.1371\/journal.pone.0204695","article-title":"Abnormal CSF amyloid-beta42 and tau levels in hip fracture patients without dementia","volume":"13","author":"ES Oh","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"pone.0225178.ref043","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/1740774516687253","article-title":"Design considerations of a randomized controlled trial of sedation level during hip fracture repair surgery: a strategy to reduce the incidence of postoperative delirium in elderly patients","volume":"14","author":"T Li","year":"2017","journal-title":"Clin Trials"},{"issue":"3","key":"pone.0225178.ref044","first-page":"189","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"MF Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"1","key":"pone.0225178.ref045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1017\/S003329170002691X","article-title":"A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation","volume":"24","author":"AF Jorm","year":"1994","journal-title":"Psychol Med"},{"issue":"6","key":"pone.0225178.ref046","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","article-title":"Age-specific and sex-specific prevalence of cerebral beta-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50\u201395 years: a cross-sectional study","volume":"16","author":"CR Jack","year":"2017","journal-title":"Lancet Neurol"},{"issue":"5","key":"pone.0225178.ref047","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"CR Jack","year":"2016","journal-title":"Neurology"},{"issue":"1\u20132","key":"pone.0225178.ref048","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000345605","article-title":"Molecular neuropsychology: creation of test-specific blood biomarker algorithms","volume":"37","author":"SE O'Bryant","year":"2014","journal-title":"Dement Geriatr Cogn Disord"},{"key":"pone.0225178.ref049","author":"L. Breiman","year":"2001","journal-title":"Random Forests"},{"issue":"5","key":"pone.0225178.ref050","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/archneurol.2011.3029","article-title":"Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging","volume":"69","author":"JL Whitwell","year":"2012","journal-title":"Arch Neurol"},{"issue":"19","key":"pone.0225178.ref051","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census","volume":"80","author":"LE Hebert","year":"2013","journal-title":"Neurology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T15:56:45Z","timestamp":1612367805000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225178"}},"subtitle":[],"editor":[{"given":"Kewei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":51,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0225178","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]}}}